Prior radiation therapy to the pelvis that would result in overlap of radiation therapy fields
285.0
Patient must not have had previous irradiation to the head and neck that would result in overlap in radiation fields for the current disease
345.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
700.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
37.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
545.0
Prior radiotherapy, including brachytherapy, to the region of the study cancer that would result in overlap of radiation therapy fields
2580.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields except patients who have progressed following stereotactic radiosurgery for 1-3 brain metastases, with at least one new lesion
143.0
Prior radiotherapy to the region of the liver that would result in excessive doses to normal tissues due to overlap of radiation therapy fields
368.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
252.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
660.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
234.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
330.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
924.0
Prior radiotherapy to the region of the liver that would result in overlap of radiation therapy fields
182.0
Prior radiotherapy to the head or neck (except for T1 glottic cancer), resulting in overlap of radiation fields
606.0
Prior radiotherapy to the head or neck (except for T1 glottic cancer), resulting in overlap of radiation fields
302.0
Prior receipt of radiotherapy that would result in overlap of the new and old radiation therapy fields
45.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
56.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
612.0
Prior radiotherapy, including brachytherapy, to the region of the study cancer that would result in overlap of radiation therapy treatment volumes
282.0
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields (to include Y90)
186.0